Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 17/20 | 0.38 |
| ▸ | HDAC3 | O15379 | 16/20 | 0.38 |
| ▸ | HDAC4 | P56524 | 16/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 16/20 | 0.38 |
| ▸ | HDAC7 | Q8WUI4 | 16/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 16/20 | 0.38 |
| ▸ | HDAC10 | Q969S8 | 16/20 | 0.38 |
| ▸ | HDAC11 | Q96DB2 | 16/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 16/20 | 0.38 |
| ▸ | HDAC9 | Q9UKV0 | 16/20 | 0.38 |
| ▸ | HDAC5 | Q9UQL6 | 16/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4788566 | 0.82 | HDAC6 (0.36) | HDAC6HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL3780094 | 0.82 | HDAC3 (0.41) | HDAC6HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL8242146 | 0.78 | HDAC6 (0.55) | HDAC6HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL8203628 | 0.77 | KDM1A (0.42) | HDAC6HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL3778383 | 0.76 | HDAC6 (0.37) | HDAC6HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL1012083 | 0.75 | POLB (0.50) | HDAC6HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL12723172 | 0.74 | HDAC3 (0.65) | HDAC6HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL1011771 | 0.74 | PIK3CA (0.48) | POLBADRA1AMEN1KMT2A | |
| SCHEMBL1010727 | 0.74 | POLB (0.67) | HDAC6HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL1080350 | 0.74 | HDAC3 (0.67) | HDAC6HDAC3HDAC4HDAC1HDAC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7932246-B2 | Histone deacetylase inhibitors | CHROMA THERAPEUTICS LTD. (GB) | 2011-04-26 | — | — | US | disclosed |
| US-7932246-B2 | Histone deacetylase inhibitors | CHROMA THERAPEUTICS LTD. (GB) | 2011-04-26 | — | — | US | disclosed |
| US-7932246-B2 | Histone deacetylase inhibitors | CHROMA THERAPEUTICS LTD. (GB) | 2011-04-26 | — | — | US | disclosed |
| EP-1881977-B1 | HISTONE DEACETYLASE INHIBITORS | CHROMA THERAPEUTICS LTD (GB) | 2011-01-05 | — | — | EP | disclosed |
| EP-1881977-B1 | HISTONE DEACETYLASE INHIBITORS | CHROMA THERAPEUTICS LTD (GB) | 2011-01-05 | — | — | EP | disclosed |
| US-20100152155-A1 | Histone Deacetylase Inhibitors | CHROMA THERAPEUTICS LTD. (GB) | 2010-06-17 | — | — | US | disclosed |
| US-20100152155-A1 | Histone Deacetylase Inhibitors | CHROMA THERAPEUTICS LTD. (GB) | 2010-06-17 | — | — | US | disclosed |
| US-20100152155-A1 | Histone Deacetylase Inhibitors | CHROMA THERAPEUTICS LTD. (GB) | 2010-06-17 | — | — | US | disclosed |
| WO-2006123121-A1 | HISTONE DEACETYLASE INHIBITORS | CHROMA THERAPEUTICS LTD (GB) | 2006-11-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152155-A1 | Histone Deacetylase Inhibitors | HDAC1, HDAC2, HDAC11 | HDAC6 10/4885HDAC3 6/4885HDAC4 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.